advertisement
Ruling delays generic Lipitor until 2011
A patent dispute agreement between drugmaker Pfizer and generic drugmaker Ranbaxy Laboratories Ltd. means that generic versions of the cholesterol drug Lipitor won't be available on the U.S. market until November 30, 2011. Pfizer officials say the agreement will allow patients much earlier access to the generic formula of Lipitor. It will also give Pfizer more time to develop replacements for Lipitor before generic versions go on the market.
(HealthDay News) UPDATED 06/19/2008Click here to read the full story
Conditions: | atherosclerosis - 406 Articles | heart disease - 622 Articles | high cholesterol - 483 Articles | stroke - 502 Articles Treatments: | Lipitor - 169 Articles
Helpful?
advertisement
